Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
PONIF$0.12-0.00(-3.70%)Silver Pony Announces Closing of Up-Sized $1,600,015 Strategic Unit Offering[6:15:00 PM ET]ELME$0.07-1.70(-96.19%)Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026[5:47:00 PM ET]HHH$72.57+3.08(+4.43%)Howard Hughes Holdings Set to Join S&P SmallCap 600 Howard Hughes Holdings Inc. (NYSE: HHH) will replace Arcosa Inc. (NYSE: ACA) in the S&P SmallCap 600 effective prior to the opening of trading on...[5:45:00 PM ET]ALGRF$0.400.00(0.00%)Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita[5:30:00 PM ET]ZEFIF$0.45+0.02(+3.56%)Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million[5:29:00 PM ET]BLK$1,118.50-18.79(-1.65%)BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF[5:23:34 PM ET]ITFS$1.43-0.02(-1.10%)Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast[5:15:00 PM ET]FAGI$0.01-0.00(-13.33%)Full Alliance Group, Inc (OTC:FAGI) YAHBEE Highlights Community-Commerce Model for Agentic Commerce Era[5:15:00 PM ET]TGT$152.76-5.35(-3.38%)Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores[5:05:00 PM ET]NU$15.23+0.50(+3.39%)Notice to Market: Nu Holdings Ltd.[5:03:00 PM ET]POR$44.55-0.35(-0.78%)Portland General Electric Declares Dividend[5:00:00 PM ET]ANTX$3.55-0.09(-2.47%)AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)[5:00:00 PM ET]

COR · NYSE

Cencora, Inc.

$331.00 -7.29 (-2.15%)

Company overview

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals, health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.

Sector
Healthcare
Industry
Medical - Distribution
Exchange
NYSE
Market cap
$63.2B
Employees
47,000
Headquarters
Conshohocken, PA
CEO
Robert Mauch
Listed
April 4, 1995
P/E
25.23
Dividend yield
0.76%

Company financials

Revenue
$329B
Gross profit
$11.4B
Operating income
$4.2B
EBITDA
$4.1B
Net income
$2.5B
EPS
$13.12
Total assets
$81.7B
Total debt
$12.4B
Gross margin
3.47%
Net margin
0.78%
Earnings yield
3.96%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

240.79267.97295.14322.31349.49
COR 1D NYSE O344.43H344.43L337.11C338.48-1.95 (-0.57%)Vol1.18M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
COR Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD) GlobeNewswire
COR Stock news Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast Defense World
COR Stock news AI Disruption May Benefit Cencora More Than Hims & Hers Seeking Alpha
COR Stock news AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
COR Stock news Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow Seeking Alpha
COR Press release Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release Business Wire
COR Stock news Cencora Elects Robert E. Sanchez to Its Board of Directors Business Wire
COR Stock news Here's Why Cencora (COR) is a Strong Growth Stock Zacks Investment Research
COR Stock news Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 MarketBeat
COR Stock news Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference MarketBeat
COR Stock news Here's Why Cencora (COR) is a Strong Value Stock Zacks Investment Research
COR Stock news Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript Seeking Alpha
COR Stock news Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
COR Stock news Here's Why Cencora (COR) is a Strong Momentum Stock Zacks Investment Research
COR Stock news Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Seeking Alpha
COR Stock news Why Cencora (COR) is a Top Growth Stock for the Long-Term Zacks Investment Research
COR Stock news Here's Why You Should Retain Cencora Stock in Your Portfolio for Now Zacks Investment Research
COR Stock news Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? Zacks Investment Research
COR Stock news Cencora Launches Cell and Gene Therapy Enablement for Health Systems Zacks Investment Research
COR Stock news Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen Zacks Investment Research
FAQ

Questions about Cencora, Inc.

What does Cencora, Inc. do?
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals, health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
What is COR's market cap?
Cencora, Inc. (COR) is a listed stock with a live quote. The latest market cap on this page is $63.2B.
Where is Cencora, Inc. headquartered?
Cencora, Inc. is headquartered in Conshohocken, PA.
How do I get COR news from the API?
Call GET /v1/news?tickers=COR. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does COR news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for COR, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the COR price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.